A Defining Moment for Cancer Immunotherapy During ESMO 2026 – Agenus

A Defining Moment for Cancer Immunotherapy During ESMO 2026 – Agenus

Agenus shared on LinkedIn:

“Bold Science. Big Questions. A Defining Moment for Cancer Immunotherapy.

On Saturday, October 24, at 6:15 PM in Madrid, Jennifer S. Buell, joins global oncology leaders, including Prof. Jean-Yves Blay, Dr. Julie Gralow, and Martha Raymond for OncoDaily’s Big Questions discussion.

The science is advancing.

The urgency is real.

Some countries are already acting.

How quickly can we bring promising breakthroughs to patients around the world?

Big Questions During ESMO 2026

ESMO 2026 | October 24 | 6:15 PM | Madrid.”

Other articles about ESMO 2026 and Immunotherapy on OncoDaily.